Cargando…
IL-35 interferes with splenic T cells in a clinical and experimental model of acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS) is a life-threatening critical care syndrome with uncontrolled inflammation that is a central issue. Its main characteristic is inflammatory mediators and cytokines as well as agglutinating chemokines that injure target cells. Interleukin (IL)-35 is a newly...
Autores principales: | Wang, Chuan-jiang, Zhang, Mu, Wu, Hua, Lin, Shi-hui, Xu, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057607/ https://www.ncbi.nlm.nih.gov/pubmed/30584968 http://dx.doi.org/10.1016/j.intimp.2018.12.024 |
Ejemplares similares
-
Antiplatelet Therapy for Acute Respiratory Distress Syndrome
por: Chen, Chuan-Mu, et al.
Publicado: (2020) -
Potential therapeutic effects of interleukin-35 on the differentiation of naïve T cells into Helios(+)Foxp3(+) Tregs in clinical and experimental acute respiratory distress syndrome
por: Wang, Chuanjiang, et al.
Publicado: (2021) -
Granulomatosis with polyangiitis (Wegener’s) complicated by splenic rupture and severe acute respiratory distress syndrome: A case report
por: Ahmad, Yannis, et al.
Publicado: (2021) -
Acute lung injury and acute respiratory distress syndrome: experimental and clinical investigations
por: Chen, Hsing I
Publicado: (2011) -
Colchicine reduces lung injury in experimental acute respiratory distress syndrome
por: Dupuis, Jocelyn, et al.
Publicado: (2020)